healthcare.digital October 31, 2017
Lucy Jones

The year is 2027. Dorothy visits her GP about panic attacks she’s been getting at work. Before prescribing any treatment, the doctor looks at her genetic history for markers that could affect her response to certain drugs. The GP is looking in particular for CYP2C19 polymorphism, which would mean Dorothy can’t metabolise a group of medicines (SSRIs); and at the same time, she examines her patient’s sequenced DNA to see if she carries the genetic mutation responsible for panic disorder. Dorothy is a heavy drinker and her doctor sees that she carries a risk gene for alcohol dependence. She considers a drug that could modulate the gene. Dorothy leaves with a smartwatch to log her daily life for the next...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Precision Medicine, Technology
Epic's new interoperability push, explained
Your Earphones And Headphones As Health And Medical Devices
277 million patients' data drives Epic's research findings
Google digs deeper into healthcare AI: 5 notes
Wearable Devices for Parkinson’s Disease: The Future Is Here

Share This Article